FATE

Fate Therapeutics, Inc. [FATE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

FATE Stock Summary

Top 10 Correlated Stocks

FATE


In the News

FATE Financial details

Company Rating
-
Market Cap
572.6M
Income
-151.22M
Revenue
63.53M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
181
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-2.8
Forward P/E
-
PEG
0.68
P/S
4.09
P/B
1.08
P/C
-
P/FCF
-2.37
Quick Ratio
8.5
Current Ratio
8.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.54
EPS next Y
-
EPS next Q
-
EPS this Y
-37.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.78%
Revenue last 5Y
42.85%
Revenue Q/Q
-13.79%
EPS Q/Q
-2.17%
-
-
-
-
SMA20
9.57%
SMA50
-22.56%
SMA100
-52.97%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-34%
ROC
-0.41%
Gross Margin
100%
Oper. Margin
-195%
Profit Margin
-146%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.63-8.83
52W High
-84.38%
52W Low
+25%
RSI
63.4
Rel Volume
2.02
Avg Volume
2.83M
Volume
5.74M
Perf Week
35.93%
Perf Month
23.76%
Perf Quarter
-55.52%
Perf Half Y
-60.32%
-
-
-
-
Beta
1.681
-
-
Volatility
0.1%, 0.12%
Prev Close
12.61%
Price
1.25
Change
21.36%

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap